Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Santa Fe, NM
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Charlotte, NC
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Dallas, TX
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Lyon cedex 04,
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Lyon cedex 04,
Click here to add this to my saved trials
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
A Pilot Project to Operationalize the Prevention Strategy of Post Exposure Prophylaxis Following Sexual Exposure to HIV in Combination With Educational Programming and Behavioral Risk Reduction Strategies in Los Angeles County
Status: Enrolling
Updated:  12/15/2017
L.A. Gay & Lesbian Center
mi
from
Los Angeles, CA
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
A Pilot Project to Operationalize the Prevention Strategy of Post Exposure Prophylaxis Following Sexual Exposure to HIV in Combination With Educational Programming and Behavioral Risk Reduction Strategies in Los Angeles County
Status: Enrolling
Updated: 12/15/2017
L.A. Gay & Lesbian Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
A Pilot Project to Operationalize the Prevention Strategy of Post Exposure Prophylaxis Following Sexual Exposure to HIV in Combination With Educational Programming and Behavioral Risk Reduction Strategies in Los Angeles County
Status: Enrolling
Updated:  12/15/2017
Oasis Clinic
mi
from
Los Angeles, CA
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
A Pilot Project to Operationalize the Prevention Strategy of Post Exposure Prophylaxis Following Sexual Exposure to HIV in Combination With Educational Programming and Behavioral Risk Reduction Strategies in Los Angeles County
Status: Enrolling
Updated: 12/15/2017
Oasis Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Lombardi Comprehensive Cancer Center at Georgetown University
mi
from
Washington,
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Lombardi Comprehensive Cancer Center at Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Boston Med Ctr
mi
from
Boston, MA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Montefiore Medical Center
mi
from
Bronx, NY
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Click here to add this to my saved trials
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Status: Enrolling
Updated:  12/19/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Status: Enrolling
Updated: 12/19/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Status: Enrolling
Updated:  12/19/2017
Grady Infectious Diseases Clinic (Ponce Clinic)
mi
from
Atlanta, GA
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Status: Enrolling
Updated: 12/19/2017
Grady Infectious Diseases Clinic (Ponce Clinic)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine (Fluzone High Dose) in Immunocompromised Children and Young Adults.
Status: Enrolling
Updated:  12/21/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine (Fluzone High Dose) in Immunocompromised Children and Young Adults.
Status: Enrolling
Updated: 12/21/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Scale-up of an Internet-Delivered Study for HIV+ Men
Scale-up of an Internet-Delivered Randomized Controlled Trial for HIV+ Men
Status: Enrolling
Updated:  12/27/2017
Public Health Solutions
mi
from
New York, NY
Scale-up of an Internet-Delivered Study for HIV+ Men
Scale-up of an Internet-Delivered Randomized Controlled Trial for HIV+ Men
Status: Enrolling
Updated: 12/27/2017
Public Health Solutions
mi
from
New York, NY
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
1220.48.0008 Boehringer Ingelheim Investigational Site
mi
from
Bakersfield, CA
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
1220.48.0008 Boehringer Ingelheim Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
1241.21.0004 Boehringer Ingelheim Investigational Site
mi
from
San Francisco, CA
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
1241.21.0004 Boehringer Ingelheim Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
California Pacific Medical Center
mi
from
San Francisco, CA
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
Albany Medical College, MC 142
mi
from
Albany, NY
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
Albany Medical College, MC 142
mi
from
Albany, NY
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
1199.15.10008 Boehringer Ingelheim Investigational Site
mi
from
Providence, RI
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
1199.15.10008 Boehringer Ingelheim Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated:  12/27/2017
Hopital de l'Hotel Dieu
mi
from
Lyon cedex 02,
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Status: Enrolling
Updated: 12/27/2017
Hopital de l'Hotel Dieu
mi
from
Lyon cedex 02,
Click here to add this to my saved trials
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders
Status: Enrolling
Updated:  12/29/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders
Status: Enrolling
Updated: 12/29/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Status: Enrolling
Updated:  1/3/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Status: Enrolling
Updated: 1/3/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Dipyridamole for Immune Activation in HIV
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
Status: Enrolling
Updated:  1/4/2018
Pitt Treatment Evaluation Unit / University of Pittsburgh
mi
from
Pittsburgh, PA
Dipyridamole for Immune Activation in HIV
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
Status: Enrolling
Updated: 1/4/2018
Pitt Treatment Evaluation Unit / University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Ucsf Aids Crs
mi
from
San Francisco, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Ucsf Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Denver Public Health CRS
mi
from
Denver, CO
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Denver Public Health CRS
mi
from
Denver, CO
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Stanford CRS
mi
from
Palo Alto, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Stanford CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Ucsd, Avrc Crs
mi
from
San Diego, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Ucsd, Avrc Crs
mi
from
San Diego, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
University of Colorado Hospital CRS
mi
from
Aurora, CO
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Georgetown University CRS (GU CRS)
mi
from
Washington,
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Georgetown University CRS (GU CRS)
mi
from
Washington,
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
University of Miami AIDS CRS
mi
from
Miami, FL
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
University of Miami AIDS CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Northwestern University CRS
mi
from
Chicago, IL
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
IHV Baltimore Treatment CRS
mi
from
Baltimore, MD
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
IHV Baltimore Treatment CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Brigham and Women's Hosp. ACTG CRS
mi
from
Boston, MA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Brigham and Women's Hosp. ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Bmc Actg Crs
mi
from
Boston, MA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Bmc Actg Crs
mi
from
Boston, MA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials